drugset / Trial / NCT03564119
A Study of S5G4T-1 in the Treatment of Papularpustular Rosacea
RandomizedParallel-groupDouble-blindTreatment
Summary
To assess the efficacy and safety of S5G4T-1 compared to S5G4T-1 vehicle when applied once daily for 12 weeks in participants with papulopustular rosacea.
Timeline
- Start
- 2018-06-21
- Primary completion
- 2019-06-10
- Completion
- 2019-06-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | S5G4T-1 | Unknown | 5 % | Topical |